RECRUITING

Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.

Official Title

Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial: Implementation of Screening and Brief Intervention

Quick Facts

Study Start:2023-06-01
Study Completion:2028-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06565416

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Willing and able to provide informed consent
  2. * have English comprehension and proficiency
  3. * receiving services at one of our participating study sites
  4. * report current chronic pain and/or opioid misuse/opioid use disorder
  5. * self-identify as American Indian/Alaska Native
  1. * if they have a psychiatric, cognitive, or medical condition that interferes with the consenting process

Contacts and Locations

Study Contact

Kamilla L Venner, PhD
CONTACT
5059252300
kamilla@unm.edu
Angel R Vasquez, PhD
CONTACT
vasquez@unm.edu

Principal Investigator

Matthew R Pearson, PhD
PRINCIPAL_INVESTIGATOR
University of New Mexico

Study Locations (Sites)

Clinic Site A (blinded pending tribal approval)
Arcata, California, 95521
United States
Clinic Site C (blinded pending tribal approval)
Minneapolis, Minnesota, 55404
United States
Clinic Site B (blinded pending tribal approval)
Toppenish, Washington, 98948
United States

Collaborators and Investigators

Sponsor: University of New Mexico

  • Matthew R Pearson, PhD, PRINCIPAL_INVESTIGATOR, University of New Mexico

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-01
Study Completion Date2028-07

Study Record Updates

Study Start Date2023-06-01
Study Completion Date2028-07

Terms related to this study

Additional Relevant MeSH Terms

  • Opioid Use Disorder
  • Opioid Misuse
  • Chronic Pain